Ester Falconer - Net Worth and Insider Trading

Ester Falconer Net Worth

The estimated net worth of Ester Falconer is at least $0 dollars as of 2024-11-13. Ester Falconer is the Chief Technology Officer of AbCellera Biologics Inc and owns about 0 shares of AbCellera Biologics Inc (ABCL) stock worth over $0. Details can be seen in Ester Falconer's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ester Falconer has not made any transactions after 2021-06-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Ester Falconer

To

Ester Falconer Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ester Falconer owns 1 companies in total, including AbCellera Biologics Inc (ABCL) .

Click here to see the complete history of Ester Falconer’s form 4 insider trades.

Insider Ownership Summary of Ester Falconer

Ticker Comapny Transaction Date Type of Owner
ABCL AbCellera Biologics Inc 2021-06-09 Chief Technology Officer

Ester Falconer Latest Holdings Summary

Ester Falconer currently owns a total of 1 stock. Ester Falconer owns 0 shares of AbCellera Biologics Inc (ABCL) as of June 9, 2021, with a value of $0.

Latest Holdings of Ester Falconer

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ABCL AbCellera Biologics Inc 2021-06-09 0 2.95 0

Holding Weightings of Ester Falconer


Ester Falconer Form 4 Trading Tracker

According to the SEC Form 4 filings, Ester Falconer has made a total of 1 transactions in AbCellera Biologics Inc (ABCL) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in AbCellera Biologics Inc is the sale of 1,000,000 shares on June 9, 2021, which brought Ester Falconer around $26 Million.

Insider Trading History of Ester Falconer

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ester Falconer Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ester Falconer Ownership Network

Ownership Network List of Ester Falconer

No Data

Ownership Network Relation of Ester Falconer

Insider Network Chart

Ester Falconer Owned Company Details

What does AbCellera Biologics Inc do?

Who are the key executives at AbCellera Biologics Inc?

Ester Falconer is the Chief Technology Officer of AbCellera Biologics Inc. Other key executives at AbCellera Biologics Inc include 10 percent owner Thermopylae Holdings Ltd. , director & Chief Operating Officer Veronique Lecault , and Chief Financial Officer Andrew Booth .

AbCellera Biologics Inc (ABCL) Insider Trades Summary

Over the past 18 months, Ester Falconer made no insider transaction in AbCellera Biologics Inc (ABCL). Other recent insider transactions involving AbCellera Biologics Inc (ABCL) include a net purchase of 436,516 shares made by Thermopylae Holdings Ltd. , a net purchase of 50,000 shares made by Michael R Hayden , and a net purchase of 30,000 shares made by John S. Montalbano .

In summary, during the past 3 months, insiders sold 0 shares of AbCellera Biologics Inc (ABCL) in total and bought 283,516 shares, with a net purchase of 283,516 shares. During the past 18 months, 0 shares of AbCellera Biologics Inc (ABCL) were sold and 551,016 shares were bought by its insiders, resulting in a net purchase of 551,016 shares.

AbCellera Biologics Inc (ABCL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AbCellera Biologics Inc Insider Transactions

No Available Data

Ester Falconer Mailing Address

Above is the net worth, insider trading, and ownership report for Ester Falconer. You might contact Ester Falconer via mailing address: C/o Abcellera Biologics Inc., 2215 Yukon Street, Vancouver A1 V5y 0a1.